ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.04
      1.10%
      US Tech 100
      21,198.40
      1.36%
      Dow Jones
      43,297.03
      0.91%
      Brent Oil
      73.285
      0.00%
      Bitcoin
      99,110.55
      0.44%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Hemostemix Inc (PK) (HMTXF) Quote

      Hemostemix Inc (PK)

      Hemostemix Inc (PK) (HMTXF)

      USOTC
      0.04679
      0.00
      (0.00%)
      Closed December 25 4:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.04679
      Bid
      0.0001
      Ask
      24,000.09
      Volume
      -
      0.00 Day's Range 0.00
      0.024 52 Week Range 0.079
      Market Cap
      5.801M
      Previous Close
      0.04679
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      27,098
      Shares Outstanding
      123,976,793
      Dividend Yield
      -
      PE Ratio
      -3.47
      Earnings Per Share (EPS)
      -0.02
      Revenue
      200k
      Net Profit
      -2.5M

      About Hemostemix Inc (PK)

      Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Blank Checks
      Website
      www.hemostemix.com
      Headquarters
      Calgary, Alberta, Can
      Founded
      2014
      Hemostemix Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker HMTXF. The last closing price for Hemostemix (PK) was $0.05. Over the last year, Hemostemix (PK) shares have traded in a share price range of $ 0.024 to $ 0.079.

      Hemostemix (PK) currently has 123,976,793 shares outstanding. The market capitalization of Hemostemix (PK) is $5.80 million. Hemostemix (PK) has a price to earnings ratio (PE ratio) of -3.47.

      Ask ADVFN Intelligence (AI)

      HMTXF Latest News

      More News

      Financing & Partnership News Send Shares of this Stem-Cell Therapy Company on a Tear

      While most stock indices are in the red today, shares of this pioneering stem cell firm are soaring following this morning's news of an LOI. In a press release this morning, Hemostemix Inc To read...

      June 03 2024
      AllPennyStocks.com

      HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

        HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT     May 10, 2021, Calgary, Alberta -- InvestorsHub NewsWire -- Hemostemix Inc...

      May 11 2021
      InvestorsHub NewsWire

      Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

       Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list  Calgary, Alberta, April 23, 2021-- InvestorsHub NewsWire -- Hemostemix Inc. ("Hemostemix" or the...

      April 26 2021
      InvestorsHub NewsWire

      Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

        Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and  Litigation Updates   Calgary, Alberta, April 12, 2021-- InvestorsHub NewHemostemix Inc...

      April 12 2021
      InvestorsHub NewsWire

      Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

      Hemostemix Annonces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets LTD.   Calgary, Alberta, April 8, 2021 -- InvestorsHub NewsWire...

      April 09 2021
      InvestorsHub NewsWire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.000380.8187890540830.046410.046790.04641100780.04679CS
      4-0.00907-16.23702112420.055860.0640.0438131710.04979165CS
      12-0.01821-28.01538461540.0650.0780.0323270980.04939305CS
      260.0159951.91558441560.03080.0790.024221180.05197266CS
      52-0.01261-21.2289562290.05940.0790.024179320.05012854CS
      156-0.05851-55.56505223170.10530.32790.024210270.13571115CS
      2600.04189854.8979591840.00490.43720.0049342300.08225982CS

      HMTXF - Frequently Asked Questions (FAQ)

      What is the current Hemostemix (PK) share price?
      The current share price of Hemostemix (PK) is $ 0.04679
      How many Hemostemix (PK) shares are in issue?
      Hemostemix (PK) has 123,976,793 shares in issue
      What is the market cap of Hemostemix (PK)?
      The market capitalisation of Hemostemix (PK) is USD 5.8M
      What is the 1 year trading range for Hemostemix (PK) share price?
      Hemostemix (PK) has traded in the range of $ 0.024 to $ 0.079 during the past year
      What is the PE ratio of Hemostemix (PK)?
      The price to earnings ratio of Hemostemix (PK) is -3.47
      What is the cash to sales ratio of Hemostemix (PK)?
      The cash to sales ratio of Hemostemix (PK) is 43.75
      What is the reporting currency for Hemostemix (PK)?
      Hemostemix (PK) reports financial results in CAD
      What is the latest annual turnover for Hemostemix (PK)?
      The latest annual turnover of Hemostemix (PK) is CAD 200k
      What is the latest annual profit for Hemostemix (PK)?
      The latest annual profit of Hemostemix (PK) is CAD -2.5M
      What is the registered address of Hemostemix (PK)?
      The registered address for Hemostemix (PK) is SUITE 1150, 707-7TH AVE SW, CALGARY, CALGARY, ALBERTA, T2P 3H6
      What is the Hemostemix (PK) website address?
      The website address for Hemostemix (PK) is www.hemostemix.com
      Which industry sector does Hemostemix (PK) operate in?
      Hemostemix (PK) operates in the BLANK CHECKS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CLGPFClean Seed Cap Group Limited (CE)
      $ 0.05
      (4,999,900.00%)
      		59.7k
      EWGFFEat Well Investment Group Inc (CE)
      $ 0.03
      (2,999,900.00%)
      		90.12k
      EGSEEvergreen Sustainable Enterprises Inc (CE)
      $ 0.0007
      (69,900.00%)
      		150
      FBECFBEC Worldwide Inc (CE)
      $ 0.0005
      (49,900.00%)
      		10k
      HLCOHealing Company Inc (CE)
      $ 0.0005
      (49,900.00%)
      		8k
      GTMIFGastem Inc (CE)
      $ 0.000001
      (-100.00%)
      		110k
      QGRSFQ2 Gold Resources Inc (CE)
      $ 0.000001
      (-99.90%)
      		13.48k
      STTOSITO Mobile Ltd (CE)
      $ 0.000002
      (-99.82%)
      		4.09k
      CRGPCalissio Resources Group Inc (CE)
      $ 0.000001
      (-99.75%)
      		3.97k
      SIRCSolar Integrated Roofing Corporation (PK)
      $ 0.000001
      (-99.00%)
      		9.25M
      HMBLHUMBL Inc (PK)
      $ 0.0008
      (14.29%)
      		312.88M
      GRLFGreen Leaf Innovations Inc (PK)
      $ 0.0001
      (-50.00%)
      		131.64M
      PHILPHI Group Inc (PK)
      $ 0.0003
      (0.00%)
      		112.89M
      DNAXDNA Brands Inc (PK)
      $ 0.0002
      (0.00%)
      		74.37M
      GTVHGolden Triangle Ventures Inc (PK)
      $ 0.0005
      (25.00%)
      		67.86M

      HMTXF Discussion

      View Posts
      JamesMacho JamesMacho 1 year ago
      Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.
      👍️0
      tw0122 tw0122 1 year ago
      Boom boom time
      👍️0

      Your Recent History

      USOTC
      HMTXF
      Hemostemix (PK)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads